These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34244053)

  • 1. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.
    Iida H; Tani M; Komeda K; Nomi T; Matsushima H; Tanaka S; Ueno M; Nakai T; Maehira H; Mori H; Matsui K; Hirokawa F; Kaibori M; Kubo S
    HPB (Oxford); 2022 Jan; 24(1):101-115. PubMed ID: 34244053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis.
    Furukawa K; Tsunematsu M; Tanji Y; Ishizaki S; Akaoka M; Haruki K; Uwagawa T; Onda S; Matsumoto M; Ikegami T
    Surg Oncol; 2023 Apr; 47():101911. PubMed ID: 36773544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
    Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
    Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer.
    Wang W; Gu J; Liu Y; Liu X; Jiang L; Wu C; Liu J
    Cancer Manag Res; 2022; 14():2803-2812. PubMed ID: 36160036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
    Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
    Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictive value of the CRP-albumin-lymphocyte index for prognosis of critically ill patients with sepsis in intensive care unit: a retrospective single-center observational study.
    Zhang J; Zhao Q; Liu S; Yuan N; Hu Z
    Front Public Health; 2024; 12():1395134. PubMed ID: 38841671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy.
    Tsunematsu M; Haruki K; Taniai T; Tanji Y; Shirai Y; Furukawa K; Uwagawa T; Onda S; Yanagaki M; Usuba T; Nakabayashi Y; Okamoto T; Ikegami T
    Ann Gastroenterol Surg; 2023 May; 7(3):503-511. PubMed ID: 37152771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
    Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
    In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
    Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
    Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
    Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
    BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index.
    Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Michel M; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Kloeckner R
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer.
    Ma R; Okugawa Y; Shimura T; Yamashita S; Sato Y; Yin C; Uratani R; Kitajima T; Imaoka H; Kawamura M; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
    Surg Oncol; 2024 Apr; 53():102044. PubMed ID: 38335851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer.
    Tsai YT; Ko CA; Chen HC; Hsu CM; Lai CH; Lee YC; Tsai MS; Chang GH; Huang EI; Fang KH
    J Cancer; 2022; 13(10):3000-3012. PubMed ID: 36046647
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery.
    Feng J; Wang L; Yang X; Chen Q
    Sci Rep; 2024 Jan; 14(1):713. PubMed ID: 38184747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
    Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
    J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.